Although the underlying cellular processes are not well understood,inflammation has long been linked to the loss of key tumor suppressorgene NKX3.1 and prostate cancer progression.13 However, there have been conflicting reports regarding the NKX3.1expression with tumor progression. Here, NKX3-1 is linked to neoplasm.